N-2-E-4

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameN-2-E-4
Drug Alias NameN-2-E-4
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNeuropilin 2 inhibitors
TargetsNeuropilin 2
Therapy Area/IndicationsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXiamen University
China Registration ClassN/A

Develop Information

Active CompaniesXiamen University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A